The study of effect of selenium on acute phase reactants and thyroid function test in hemodialysis patients
Phase 2
- Conditions
- Hemodialysis patient.End-Stage renal disease
- Registration Number
- IRCT2014041517284N1
- Lead Sponsor
- Vice Chancellor for Research Affairs, Kermanshah University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
the patient's willingness to cooperate; at least 6 months passing after dialysis starting . Exclusion criteria: infectious diseases during last 3 months; steroidal and non-steroidal anti-inflammatory drugs; vitamins E, C and zinc usage within two months before the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Selenium. Timepoint: 90 days. Method of measurement: By cell counter.
- Secondary Outcome Measures
Name Time Method Quantity CRP. Timepoint: 3 months later. Method of measurement: Cell counter.;T3RU. Timepoint: 3months later. Method of measurement: Cell counter.;T4. Timepoint: 3months later. Method of measurement: Cell counter.;TSH. Timepoint: 3months later. Method of measurement: Cell counter.;ESR. Timepoint: 3months later. Method of measurement: Cell counter.;Ferritin. Timepoint: 3months later. Method of measurement: Cell counter.